Thermo Fisher Scientific
Pharmaindustrie
Linz
ab 500 Mitarbeiter
A big thank you to our colleagues globally for your support of our Healthier Communities initiative! Colleagues from 16 countries volunteered to pack hygiene kits, assemble prosthetic limbs, build care items for pediatric hospital patients and so much more. Their dedication is making a real difference in improving health for people and communities across the globe.
We recently welcomed @massgovernor Maura Healey to our Plainville, Massachusetts site, where we develop and manufacture technologies that help create critical vaccines and medicines. Governor Healey was joined by Interim Secretary of Economic Development Ashley Stolba, Dr. Kirk Taylor, President & CEO, Massachusetts Life Sciences Center and our @@massbio_ partners Kendalle Burlin O’Connell and Jason Cordeiro. We shared with the governor the ways our 380,000-square-foot facility plays a key role in advancing treatments for conditions such as bladder cancer, pancreatic cancer, Parkinson's disease, Rett Syndrome, Hemophilia B, Duchene's Muscular Dystrophy, and Pompe Disease. The group toured our state-of-the-art site and met the dedicated colleagues who make advancements possible. We are thankful for the opportunity to showcase the impactful work of our team. Thank you, Governor Healey, for engaging in these vital discussions and supporting scientific innovation! Photo credit Joshua Qualls/Governor’s Press Office
Our new Centre for Advanced Training and Innovative Research (CATIR) in Pretoria, South Africa, aims to help transform the future of science and healthcare on the continent. In collaboration with the South African Medical Research Council and the Department of Science, Innovation, and Technology, we will equip scientists with the expertise needed to lead research and healthcare advancements that create opportunities to retain emerging talent in the region, address local health challenges and improve patient care. "Africa needs to localize vaccine and pharmaceutical manufacturing and innovate for Africa, in Africa," says Thermo Fisher’s Marcin Kouri. This initiative is an important step toward achieving that goal. Together, we can empower the brightest minds to thrive and make a positive impact, not only in Africa, but around the globe.
Today marks a milestone in the fight against lung cancer. The FDA has approved our Oncomine Dx Target Test as a companion diagnostic to identify patients eligible for @boehringer_ingelheim's HERNEXEOS® (zongertinib tablets). This test can detect specific mutations in non-small cell lung cancer tumors, helping clinicians determine the best treatment options for patients. Lung cancer is one of the most common cancers in the United States. For patients with rare HER2-mutant non-small cell lung cancer, treatment options have been limited. HERNEXEOS® is the first and only orally administered targeted therapy for this rare form of lung cancer, offering new hope for those facing a challenging prognosis. This approval represents another important step forward in personalized medicine, ensuring that individuals receive treatments tailored to their unique genetic makeup. With the Oncomine Dx Target Test, we are empowering healthcare providers to make more informed decisions and improve patient outcomes. Together, we can transform the future of cancer treatment and bring hope to those who need it most.
At ADLM 2025, we celebrated diagnostic solutions that empower clinicians and labs to detect diseases earlier and provide patients with greater access to care. We proudly shared the FDA approval of our test that supports faster and more informed treatment decisions in oncology, as well as new diagnostic technologies designed to streamline workflows and reduce errors, allowing labs to focus on what matters most: patient care. We’re committed to addressing today’s challenges and driving tomorrow’s breakthroughs. Together, we are advancing science, improving outcomes, and expanding access to care worldwide.
Meet Bella, a 16-year-old from Kebbi, Nigeria, whose life was transformed by Project HOPE, a global non-profit that provides medical care, mental health and other support programs to communities worldwide. In a town where 32 percent of the population is illiterate and girls are not encouraged to speak out, Project HOPE provided Bella with new opportunities and training that helped develop her computer literacy and public speaking skills. She now has renewed hope and dreams of becoming a doctor to support her community. Thermo Fisher Scientific colleagues support Project HOPE and youth like Bella through a grant program and volunteer activities. We are committed to supporting programs like Project HOPE to empower people and communities globally.
A routine physical turned into a devastating cancer diagnosis for Paul Chae at age 51. An FDA-approved CAR-T cell therapy became his last option after failing out of a clinical trial to treat his lymphoma. The treatment was “revolutionary, because it had not been done before,” says Chae. Watch to learn more about how CAR-T cell therapy can help turn a patient’s own immune cells into powerful, targeted cancer-fighting agents, giving hope to patients like Chae.
Happy National Intern Day 🎉 Today, we celebrate the incredible contributions of over 300 interns at Thermo Fisher Scientific. Their fresh perspectives, ideas and curiosity are instrumental in advancing scientific innovation and creating global impact. Through hands-on work, our interns gain valuable skills and enable our customers to make the world healthier, cleaner, and safer. Thank you to all our interns for your hard work, dedication, and passion. Together, we are driving the future of science and innovation!
Hello from #ADLM2025! Earlier and more efficient detection and diagnosis of diseases can have a profound impact on patients' lives. At ADLM, we're connecting with customers and industry leaders to showcase our latest diagnostic solutions that meet evolving global healthcare demands. From technology that streamlines workflows and enhances patient safety to FDA-approved rapid next-generation sequencing that delivers results in as little as 24 hours, we're empowering care teams to make informed decisions swiftly. Together, we're making a difference in the lives of patients everywhere. Visit us at booth #2812 this week to see how we’re working to shape the future of diagnostics.
Our colleagues in Brno, Czech Republic, share more than just scientific and technological expertise—they also compete together in a local hockey league. How do skills from working with electron microscopes and spectrometers translate into team play? What do they discover about teamwork when they trade their workstations for the ice rink? Lubomir and his teammates show us how they work together to support our customers, and each other, on and off the ice.
Summer safety is key to enjoying time outdoors. Did you know we have technology that helps protect your skin from UV rays and helps determine if water is safe for swimming? Our ion chromatography system is crucial in testing for zinc oxide, the active ingredient in sunscreen, to develop high-quality sunscreens for consumers. Additionally, our liquid chromatography-mass spectrometry technologies help authorities test for water contamination, such as harmful algae blooms, so beachgoers can feel confident before taking a dip. Learn more about how our technology can help keep you safe all summer long at the link in our bio.
Gene therapies offer incredible hope for patients, from treating cancers to curing lifelong conditions like sickle cell anemia. How do they work? According to Thermo Fisher’s Namritha Ravinder, gene therapies can correct "spelling errors" in a patient’s genetic code to restore normal function. She recently joined Science with a Twist to discuss the science behind gene therapies and their potential. Listen now on our website or wherever you access your podcasts.
We’re proud to announce the launch of the Centre for Advanced Training and Innovative Research (CATIR) in Pretoria, South Africa, where we will support and train the next generation of African scientists. In partnership with South African Medical Research Council and the Department of Science, Technology and Innovation, CATIR will provide a holistic and hands-on approach to lab training using world class technology for local students. The dedicated facility is also designed to support future pandemic preparedness and local healthcare capacity.
We have expanded our long-standing partnership with Sanofi to acquire Sanofi’s steriles manufacturing site in Ridgefield, New Jersey. Under the agreement, we will continue to manufacture a portfolio of therapies for Sanofi and expand use of the site to meet the growing demand from pharma and biotech customers for U.S. manufacturing capacity. The Ridgefield site is a state-of-the-art sterile fill/finish and packaging facility with a world-class team of more than 200 employees who will join Thermo Fisher following the completion of the transaction. “Sanofi’s Ridgefield site will strengthen our U.S. manufacturing capabilities, enabling us to better support our pharmaceutical and biotech customers with the critical production capacity needed for essential medicines,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. “We will also expand and further strengthen our long-standing partnership with Sanofi, while investing to bring additional capacity and enhanced capabilities at this site. We look forward to welcoming all Ridgefield employees to Thermo Fisher later this year.” Learn more at the link in our bio.
"The technological innovations in next-generation sequencing (NGS) have truly helped usher the era of personalized medicine," says Thermo Fisher’s Kathy Davy. As a leader in pharma and clinical diagnostics for nearly 30 years, Davy brings her expertise in molecular diagnostics, NGS and clinical genomics to help advance precision oncology by bridging the gap between research and practice. Explore her perspectives on: 🚀 The evolution of NGS technology, enabling faster and more accurate diagnosis. 💡 Overcoming barriers, such as reimbursement coverage and physician education, to integrate NGS into precision oncology. 🤝 The importance of collaboration between pharmaceutical companies and academic institutions to advance cancer diagnostics. 🔍 The transformative impact of AI and machine learning to enhance diagnostic accuracy and patient outcomes. 🌐 Thermo Fisher's role in delivering advanced DNA sequencing technology to help match patients with optimal therapies and forge partnerships around the world to develop new therapies. Read more at the link in our bio.
Did you know that powerful electron microscopes help scientists develop better treatments for diseases? Cryo-electron microscopy (cryo-EM) allows scientists to capture detailed images of cells, tissues and proteins, enabling them to build realistic 3D models to understand diseases mechanisms and design effective therapies. We support this crucial research with advanced instruments and technologies. Swipe through to learn from Thermo Fisher’s Steve Reyntjens how cryo-EM accelerates scientific innovation and advances drug discovery.
A big thank you to our colleagues globally for your support of our Healthier Communities initiative! Colleagues from 16 countries volunteered to pack hygiene kits, assemble prosthetic limbs, build care items for pediatric hospital patients and so much more. Their dedication is making a real difference in improving health for people and communities across the globe.
We recently welcomed @massgovernor Maura Healey to our Plainville, Massachusetts site, where we develop and manufacture technologies that help create critical vaccines and medicines. Governor Healey was joined by Interim Secretary of Economic Development Ashley Stolba, Dr. Kirk Taylor, President & CEO, Massachusetts Life Sciences Center and our @@massbio_ partners Kendalle Burlin O’Connell and Jason Cordeiro. We shared with the governor the ways our 380,000-square-foot facility plays a key role in advancing treatments for conditions such as bladder cancer, pancreatic cancer, Parkinson's disease, Rett Syndrome, Hemophilia B, Duchene's Muscular Dystrophy, and Pompe Disease. The group toured our state-of-the-art site and met the dedicated colleagues who make advancements possible. We are thankful for the opportunity to showcase the impactful work of our team. Thank you, Governor Healey, for engaging in these vital discussions and supporting scientific innovation! Photo credit Joshua Qualls/Governor’s Press Office
Our new Centre for Advanced Training and Innovative Research (CATIR) in Pretoria, South Africa, aims to help transform the future of science and healthcare on the continent. In collaboration with the South African Medical Research Council and the Department of Science, Innovation, and Technology, we will equip scientists with the expertise needed to lead research and healthcare advancements that create opportunities to retain emerging talent in the region, address local health challenges and improve patient care. "Africa needs to localize vaccine and pharmaceutical manufacturing and innovate for Africa, in Africa," says Thermo Fisher’s Marcin Kouri. This initiative is an important step toward achieving that goal. Together, we can empower the brightest minds to thrive and make a positive impact, not only in Africa, but around the globe.
Today marks a milestone in the fight against lung cancer. The FDA has approved our Oncomine Dx Target Test as a companion diagnostic to identify patients eligible for @boehringer_ingelheim's HERNEXEOS® (zongertinib tablets). This test can detect specific mutations in non-small cell lung cancer tumors, helping clinicians determine the best treatment options for patients. Lung cancer is one of the most common cancers in the United States. For patients with rare HER2-mutant non-small cell lung cancer, treatment options have been limited. HERNEXEOS® is the first and only orally administered targeted therapy for this rare form of lung cancer, offering new hope for those facing a challenging prognosis. This approval represents another important step forward in personalized medicine, ensuring that individuals receive treatments tailored to their unique genetic makeup. With the Oncomine Dx Target Test, we are empowering healthcare providers to make more informed decisions and improve patient outcomes. Together, we can transform the future of cancer treatment and bring hope to those who need it most.
At ADLM 2025, we celebrated diagnostic solutions that empower clinicians and labs to detect diseases earlier and provide patients with greater access to care. We proudly shared the FDA approval of our test that supports faster and more informed treatment decisions in oncology, as well as new diagnostic technologies designed to streamline workflows and reduce errors, allowing labs to focus on what matters most: patient care. We’re committed to addressing today’s challenges and driving tomorrow’s breakthroughs. Together, we are advancing science, improving outcomes, and expanding access to care worldwide.
Meet Bella, a 16-year-old from Kebbi, Nigeria, whose life was transformed by Project HOPE, a global non-profit that provides medical care, mental health and other support programs to communities worldwide. In a town where 32 percent of the population is illiterate and girls are not encouraged to speak out, Project HOPE provided Bella with new opportunities and training that helped develop her computer literacy and public speaking skills. She now has renewed hope and dreams of becoming a doctor to support her community. Thermo Fisher Scientific colleagues support Project HOPE and youth like Bella through a grant program and volunteer activities. We are committed to supporting programs like Project HOPE to empower people and communities globally.
A routine physical turned into a devastating cancer diagnosis for Paul Chae at age 51. An FDA-approved CAR-T cell therapy became his last option after failing out of a clinical trial to treat his lymphoma. The treatment was “revolutionary, because it had not been done before,” says Chae. Watch to learn more about how CAR-T cell therapy can help turn a patient’s own immune cells into powerful, targeted cancer-fighting agents, giving hope to patients like Chae.
Happy National Intern Day 🎉 Today, we celebrate the incredible contributions of over 300 interns at Thermo Fisher Scientific. Their fresh perspectives, ideas and curiosity are instrumental in advancing scientific innovation and creating global impact. Through hands-on work, our interns gain valuable skills and enable our customers to make the world healthier, cleaner, and safer. Thank you to all our interns for your hard work, dedication, and passion. Together, we are driving the future of science and innovation!
Hello from #ADLM2025! Earlier and more efficient detection and diagnosis of diseases can have a profound impact on patients' lives. At ADLM, we're connecting with customers and industry leaders to showcase our latest diagnostic solutions that meet evolving global healthcare demands. From technology that streamlines workflows and enhances patient safety to FDA-approved rapid next-generation sequencing that delivers results in as little as 24 hours, we're empowering care teams to make informed decisions swiftly. Together, we're making a difference in the lives of patients everywhere. Visit us at booth #2812 this week to see how we’re working to shape the future of diagnostics.
Our colleagues in Brno, Czech Republic, share more than just scientific and technological expertise—they also compete together in a local hockey league. How do skills from working with electron microscopes and spectrometers translate into team play? What do they discover about teamwork when they trade their workstations for the ice rink? Lubomir and his teammates show us how they work together to support our customers, and each other, on and off the ice.
Summer safety is key to enjoying time outdoors. Did you know we have technology that helps protect your skin from UV rays and helps determine if water is safe for swimming? Our ion chromatography system is crucial in testing for zinc oxide, the active ingredient in sunscreen, to develop high-quality sunscreens for consumers. Additionally, our liquid chromatography-mass spectrometry technologies help authorities test for water contamination, such as harmful algae blooms, so beachgoers can feel confident before taking a dip. Learn more about how our technology can help keep you safe all summer long at the link in our bio.
Gene therapies offer incredible hope for patients, from treating cancers to curing lifelong conditions like sickle cell anemia. How do they work? According to Thermo Fisher’s Namritha Ravinder, gene therapies can correct "spelling errors" in a patient’s genetic code to restore normal function. She recently joined Science with a Twist to discuss the science behind gene therapies and their potential. Listen now on our website or wherever you access your podcasts.
We’re proud to announce the launch of the Centre for Advanced Training and Innovative Research (CATIR) in Pretoria, South Africa, where we will support and train the next generation of African scientists. In partnership with South African Medical Research Council and the Department of Science, Technology and Innovation, CATIR will provide a holistic and hands-on approach to lab training using world class technology for local students. The dedicated facility is also designed to support future pandemic preparedness and local healthcare capacity.
We have expanded our long-standing partnership with Sanofi to acquire Sanofi’s steriles manufacturing site in Ridgefield, New Jersey. Under the agreement, we will continue to manufacture a portfolio of therapies for Sanofi and expand use of the site to meet the growing demand from pharma and biotech customers for U.S. manufacturing capacity. The Ridgefield site is a state-of-the-art sterile fill/finish and packaging facility with a world-class team of more than 200 employees who will join Thermo Fisher following the completion of the transaction. “Sanofi’s Ridgefield site will strengthen our U.S. manufacturing capabilities, enabling us to better support our pharmaceutical and biotech customers with the critical production capacity needed for essential medicines,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. “We will also expand and further strengthen our long-standing partnership with Sanofi, while investing to bring additional capacity and enhanced capabilities at this site. We look forward to welcoming all Ridgefield employees to Thermo Fisher later this year.” Learn more at the link in our bio.
"The technological innovations in next-generation sequencing (NGS) have truly helped usher the era of personalized medicine," says Thermo Fisher’s Kathy Davy. As a leader in pharma and clinical diagnostics for nearly 30 years, Davy brings her expertise in molecular diagnostics, NGS and clinical genomics to help advance precision oncology by bridging the gap between research and practice. Explore her perspectives on: 🚀 The evolution of NGS technology, enabling faster and more accurate diagnosis. 💡 Overcoming barriers, such as reimbursement coverage and physician education, to integrate NGS into precision oncology. 🤝 The importance of collaboration between pharmaceutical companies and academic institutions to advance cancer diagnostics. 🔍 The transformative impact of AI and machine learning to enhance diagnostic accuracy and patient outcomes. 🌐 Thermo Fisher's role in delivering advanced DNA sequencing technology to help match patients with optimal therapies and forge partnerships around the world to develop new therapies. Read more at the link in our bio.
Did you know that powerful electron microscopes help scientists develop better treatments for diseases? Cryo-electron microscopy (cryo-EM) allows scientists to capture detailed images of cells, tissues and proteins, enabling them to build realistic 3D models to understand diseases mechanisms and design effective therapies. We support this crucial research with advanced instruments and technologies. Swipe through to learn from Thermo Fisher’s Steve Reyntjens how cryo-EM accelerates scientific innovation and advances drug discovery.
Thermo Fisher Scientific
keine Jobs